United Capital Management of KS’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,525
Closed -$29K 89
2022
Q3
$29K Sell
18,525
-4,490
-20% -$7.03K 0.01% 82
2022
Q2
$46K Sell
23,015
-6,375
-22% -$12.7K 0.02% 81
2022
Q1
$68K Buy
29,390
+400
+1% +$925 0.03% 89
2021
Q4
$135K Buy
28,990
+2,000
+7% +$9.31K 0.05% 89
2021
Q3
$206K Buy
26,990
+6,025
+29% +$46K 0.08% 90
2021
Q2
$203K Buy
+20,965
New +$203K 0.08% 94